Dose-dependent effects of erythropoietin in propofol anesthetized neonatal rats

Brain Research

Volumn 1343, Issue , 2010, Pages 14-19

  Zacharias, Robert ^a   Schmidt, Maren ^a   Kny, Jenny ^a   Sifringer, Marco ^a   Bercker, Sven ^b   Bittigau, Petra ^a   Bührer, Christoph ^a   Felderhoff Müser, Ursula ^c   Kerner, Thoralf ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d Asklepios Klinik Harburg   (Germany)

Author keywords

Erythropoietin; Neurodegeneration; Neuroprotection; Propofol

Indexed keywords

PROPOFOL; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HISTOPATHOLOGY; LOW DRUG DOSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ERYTHROPOIETIN; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAPERITONEAL; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PROPOFOL; RATS; TREATMENT OUTCOME;

ANIMALIA; RATTUS;

EID: 77953609056     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.081     Document Type: Article

References (41)

1. Beleslin-Cokic B.B., Cokic V.P., Yu X., Weksler B.B., Schechter A.N., and Noguchi C.T. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104 (2004) 2073-2080
2. Bercker S., Bert B., Bittigau P., Felderhoff-Muser U., Buhrer C., Ikonomidou C., Weise M., Kaisers U.X., and Kerner T. Neurodegeneration in newborn rats following propofol and sevoflurane anesthesia. Neurotox. Res. 16 (2009) 140-147
3. Buss R.R., and Oppenheim R.W. Role of programmed cell death in normal neuronal development and function. Anat. Sci. Int. 79 (2004) 191-197
4. Cohen J., Oren-Young L., Klingmuller U., and Neumann D. Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling. Biochem. J. 377 (2004) 517-524
5. DeOlmos J.S., and Ingram W.R. An improved cupric-silver method for impregnation of axonal and terminal degeneration. Brain Res. 33 (1971) 523-529
6. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
7. Dobbing J., and Sands J. Comparative aspects of the brain growth spurt. Early Hum. Dev. 3 (1979) 79-83
8. Dzietko M., Felderhoff-Mueser U., Sifringer M., Krutz B., Bittigau P., Thor F., Heumann R., Bührer C., Ikonomidou C., and Hansen H.H. Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity. Neurobiol. Dis. 15 (2004) 177-187
9. Fredriksson A., Ponten E., Gordh T., and Eriksson P. Neonatal exposure to a combination of N-methyl-d-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 107 (2007) 427-436
10. Gascon E., Klauser P., Kiss J.Z., and Vutskits L. Potentially toxic effects of anaesthetics on the developing central nervous system. Eur. J. Anaesthesiol. 24 (2007) 213-224
11. Genc S., Koroglu T.F., and Genc K. Erythropoietin and the nervous system. Brain Res. 1000 (2004) 19-31
12. Grasso G., Sfacteria A., Meli F., Fodale V., Buemi M., and Iacopino D.G. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res. 1182 (2007) 99-105
13. Honegger P., and Matthieu J.M. Selective toxicity of the general anesthetic propofol for GABAergic neurons in rat brain cell cultures. J. Neurosci. Res. 45 (1996) 631-636
14. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., Price M.T., Stefovska V., Horster F., Tenkova T., Dikranian K., and Olney J.W. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287 (2000) 1056-1060
15. Ishimaru M.J., Ikonomidou C., Tenkova T.I., Der T.C., Dikranian K., Sesma M.A., and Olney J.W. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J. Comp. Neurol. 408 (1999) 461-476
16. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., Zorumski C.F., Olney J.W., and Wozniak D.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 23 (2003) 876-882
17. Juul S. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. Clin. Perinatol. 31 (2004) 129-142
18. Juul S., and Felderhoff-Mueser U. Epo and other hematopoietic factors. Semin. Fetal Neonatal Med. 12 (2007) 250-258
19. Kaindl A.M., Sifringer M., Koppelstaetter A., Genz K., Loeber R., Boerner C., Stuwe J., Klose J., and Felderhoff-Mueser U. Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann. Neurol. 64 (2008) 523-534
20. Kay B., and Rolly G. I.C.I. 35868, a new intravenous induction agent. Acta Anaesthesiol. Belg. 28 (1977) 303-316
21. Kumral A., Ozer E., Yilmaz O., Akhisaroglu M., Gokmen N., Duman N., Ulukus C., Genc S., and Ozkan H. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol. Neonate 83 (2003) 224-228
22. Motsch J., and Roggenbach J. Propofol infusion syndrome. Anaesthesist. 53 (2004) 1009-1022 (quiz 1023-4)
23. Olney J.W. New insights and new issues in developmental neurotoxicology. Neurotoxicology 23 (2002) 659-668
24. Pesic V., Milanovic D., Tanic N., Popic J., Kanazir S., Jevtovic-Todorovic V., and Ruzdijic S. Potential mechanism of cell death in the developing rat brain induced by propofol anesthesia. Int. J. Dev. Neurosci. 27 (2009) 279-287
25. Rudolph U., and Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat. Rev. Neurosci. 5 (2004) 709-720
26. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4635-4640
27. Shang Y., Wu Y., Yao S., Wang X., Feng D., and Yang W. Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: Involvement of PI3K/Akt and GSK-3 beta pathway. Apoptosis 12 (2007) 2187-2195
28. Silva M., Grillot D., Benito A., Richard C., Nunez G., and Fernandez-Luna J.L. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88 (1996) 1576-1582
29. Sirén A.L., and Ehrenreich H. Erythropoietin-a novel concept for neuroprotection. Eur. Arch. Psychiatry Clin. Neurosci. 251 (2001) 179-184
30. Sirén A.L., Knerlich F., Poser W., Gleiter C.H., Brück W., and Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. 101 (2001) 271-276
31. Soriano S.G., Anand K.J., Rovnaghi C.R., and Hickey P.R. Of mice and men: should we extrapolate rodent experimental data to the care of human neonates?. Anesthesiology 102 (2005) 866-868 (author reply 868-9)
32. Spandou E., Papoutsopoulou S., Soubasi V., Karkavelas G., Simeonidou C., Kremenopoulos G., and Guiba-Tziampiri O. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain. Brain Res. 1021 (2004) 167-172
33. Spandou E., Papadopoulou Z., Soubasi V., Karkavelas G., Simeonidou C., Pazaiti A., and Guiba-Tziampiri O. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res. 1045 (2005) 22-30
34. Verdier F., Walrafen P., Hubert N., Chretien S., Gisselbrecht S., Lacombe C., and Mayeux P. Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. J. Biol. Chem. 275 (2000) 18375-18381
35. Vutskits L., Gascon E., Tassonyi E., and Kiss J.Z. Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gamma-aminobutyric acid-positive interneurons. Anesthesiology 102 (2005) 970-976
36. Weber A., Dzietko M., Berns M., Felderhoff-Mueser U., Heinemann U., Maier R.F., Obladen M., Ikonomidou C., and Bührer C. Neuronal damage after moderate hypoxia and erythropoietin. Neurobiol. Dis. 20 (2005) 594-600
37. West M.J., and Gundersen H.J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. Comp. Neurol. 296 (1990) 1-22
38. Wise-Faberowski L., Raizada M.K., and Sumners C. Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesth. Analg. 93 (2001) 1281-1287
39. Won Y.J., Yoo J.Y., Lee J.H., Hwang S.J., Kim D., and Hong H.N. Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures. Brain Res. 1154 (2007) 31-39
40. Yamasaki M., Mishima H.K., Yamashita H., Kashiwagi K., Murata K., Minamoto A., and Inaba T. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res. 1050 (2005) 15-26
41. Young C., Jevtovic-Todorovic V., Qin Y.Q., Tenkova T., Wang H., Labruyere J., and Olney J.W. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br. J. Pharmacol. 146 (2005) 189-197